| SUMMARY OF WARRANT ACTIVITY |
The
following table summarizes warrant activity for the nine months ended March 31, 2026:
SUMMARY OF WARRANT ACTIVITY
| |
|
|
|
|
Weighted |
|
| |
|
Number of |
|
|
Average |
|
| |
|
Warrants |
|
|
Price Per Share |
|
| Outstanding at June 30, 2025 |
|
|
10 |
|
|
$ |
15,000.00 |
|
| Granted – Common stock warrants |
|
|
1,200 |
|
|
|
100.00 |
|
| Granted – Series C preferred stock warrants |
|
|
9,900 |
|
|
|
10,000 |
|
| Exercised – Series C preferred stock warrants |
|
|
(100 |
) |
|
|
10,000 |
|
| Forfeited |
|
|
- |
|
|
|
- |
|
| Expired |
|
|
- |
|
|
|
- |
|
| Outstanding at March 31, 2026 |
|
|
11,010 |
|
|
$ |
8,925.52 |
|
| |
|
|
|
|
|
|
|
|
| Exercisable at March 31, 2026 |
|
|
11,010 |
|
|
$ |
8,925.52 |
|
| Outstanding and Exercisable: |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| Weighted average remaining contractual term |
|
|
3.67 |
|
|
|
|
|
| Aggregate intrinsic value |
|
$ |
- |
|
|
|
|
|
|
The
following table summarizes common stock warrant activity for the years ended June 30, 2025 and 2024:
SUMMARY OF WARRANT ACTIVITY
| |
|
|
|
|
Weighted |
|
| |
|
Number of |
|
|
Average |
|
| |
|
Warrants |
|
|
Price
Per Share |
|
| Outstanding at June 30, 2023 |
|
|
- |
|
|
$ |
8,160,000,000 |
|
| Issued |
|
|
10 |
|
|
|
15,000 |
|
| Exercised |
|
|
- |
|
|
|
- |
|
| Forfeited |
|
|
- |
|
|
|
- |
|
| Expired |
|
|
- |
|
|
|
- |
|
| Outstanding at June 30, 2024 |
|
|
10 |
|
|
$ |
31.00 |
|
| Issued |
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
| Cancelled* |
|
|
- |
|
|
|
- |
|
| Expired |
|
|
- |
|
|
|
- |
|
| Outstanding at June 30, 2025 |
|
|
10 |
|
|
$ |
0.25 |
|
| |
|
|
|
|
|
|
|
|
| Exercisable at June 30, 2025 |
|
|
10 |
|
|
$ |
0.25 |
|
| Outstanding and Exercisable: |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| Weighted average remaining contractual term |
|
|
1.01 |
|
|
|
|
|
| Aggregate intrinsic value |
|
$ |
1,035 |
|
|
|
|
|
|
* |
On
March 3, 2025, the Company cancelled all the existing warrants (de minimis number of shares of Series A warrants, Series B warrants,
and Series C warrants) held by an investor pursuant to a Warrant Exchange Agreement (see above). |
|
| SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY |
A
summary of the Company’s option activity during the nine months ended March 31, 2026 is presented below:
SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY
| |
|
|
|
|
Weighted |
|
| |
|
Number of |
|
|
Average Exercise |
|
| |
|
Shares |
|
|
Price Per Share |
|
| Outstanding at June 30, 2025 |
|
|
nil |
|
|
$ |
6,800,000,000,000 |
|
| Granted |
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
| Forfeited |
|
|
- |
|
|
|
- |
|
| Expired |
|
|
- |
|
|
|
- |
|
| Outstanding at March 31, 2026 |
|
|
nil |
|
|
$ |
6,800,000,000,000 |
|
| |
|
|
|
|
|
|
|
|
| Exercisable at March 31, 2026 |
|
|
nil |
|
|
$ |
6,800,000,000,000 |
|
| Outstanding and Exercisable: |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| Weighted average remaining contractual term |
|
|
3.12 |
|
|
|
|
|
| Weighted average fair value of options granted during the period |
|
$ |
- |
|
|
|
|
|
| Aggregate intrinsic value |
|
$ |
- |
|
|
|
|
|
|
A
summary of the Company’s stock option activity during the years ended June 30, 2025 and 2024 is presented below:
SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY
| |
|
|
|
|
Weighted |
|
| |
|
Number of |
|
|
Average |
|
| |
|
Options |
|
|
Price
Per Share |
|
| Outstanding at June 30, 2023 |
|
|
nil |
|
|
$ |
6,800,000,000,000 |
|
| Issued |
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
| Expired |
|
|
- |
|
|
|
- |
|
| Outstanding at June 30, 2024 |
|
|
nil |
|
|
$ |
6,800,000,000,000 |
|
| Issued |
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
| Expired |
|
|
- |
|
|
|
- |
|
| Outstanding at June 30, 2025 |
|
|
nil |
|
|
$ |
6,800,000,000,000 |
|
| |
|
|
|
|
|
|
|
|
| Exercisable at June 30, 2025 |
|
|
nil |
|
|
$ |
6,800,000,000,000 |
|
| Outstanding and Exercisable: |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| Weighted average remaining contractual term |
|
|
3.87 |
|
|
|
|
|
| Weighted average fair
value of options granted during the year |
|
$ |
- |
|
|
|
|
|
| Aggregate intrinsic value |
|
$ |
- |
|
|
|
|
|
|